Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Tivdak 40 mg powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
Tisotumab vedotin
Company:  
Genmab A/S See contact details
ATC code: 
L01FX23
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 29 Jan 2026

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Genmab A/S
Company image
Address
Carl Jacobsens Vej 30, Valby, 2500, Denmark
Telephone
+45 7020 2728
Medical Information Direct Line
+44 2045792977
Medical Information e-mail
[email protected]
WWW
www.genmab.com